PEAK6 Investments’s Array Biopharma Inc ARRY Stock Holding History

PEAK6 Investments’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-14,781	Closed	-$685K	–	4602
2019 Q2	$685K	Sell	14,781 -18,261	-55%	-$513K	﹤0.01%	2058
2019 Q1	$806K	Buy	+33,042	New	+$688K	﹤0.01%	2018

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

PEAK6 Investments's ARRY Position: Q3 2019 in Review

PEAK6 Investments sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 14,781 shares — an estimated $685K sold.

PEAK6 Investments first reported a position in ARRY in Q1 2019 and held it in 2 quarters. The position peaked at $806K in Q1 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

PEAK6 Investments reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
PEAK6 Investments sold 14,781 Array Biopharma Inc shares in Q3 2019, an estimated $685K.
PEAK6 Investments first reported a position in Array Biopharma Inc in Q1 2019 and held it in 2 quarters.
PEAK6 Investments's Array Biopharma Inc position peaked at $806K in Q1 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on PEAK6 Investments's 13F filing for Q3 2019, filed 8 Nov 2019.